Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Aclipse Therapeutics to acquire Cypress BioPharma

PRIVATESep 22, 2026about 3 hours ago

Acquiring Company

Aclipse Therapeutics

Acquired Company

WORQ

RadnorMalaysiaHealthcare

Description

Aclipse Therapeutics has announced an agreement to acquire Cypress BioPharma, enhancing its renal development capabilities. This acquisition would allow Aclipse to establish parallel development programs for kidney and gastrointestinal therapies. The transaction underscores Aclipse's commitment to advancing treatments for rare diseases.

Company Information

Company

Aclipse Therapeutics

Location

170 NORTH RADNOR CHESTER ROAD

Radnor, Pennsylvania, United States

About

Aclipse Therapeutics is a clinical-stage biopharmaceutical company developing best-in-class therapies for chronic, rare, and severe diseases. Their innovative approach focuses on providing solutions for patients with unmet medical needs. They are committed to advancing healthcare through effective treatment options. Aclipse aims to bring transformative therapies to market.

Fundz sees it the moment Aclipse Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Aclipse Therapeutics's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired WORQ?

WORQ was acquired by Aclipse Therapeutics, based in Radnor. The deal was reported on September 22, 2026. Aclipse Therapeutics is a clinical-stage biopharmaceutical company developing best-in-class therapies for chronic, rare, and severe diseases. Aclipse Therapeutics is privately held and operates in Healthcare.

When did Aclipse Therapeutics acquire WORQ?

Aclipse Therapeutics's acquisition of WORQ was reported on September 22, 2026. Aclipse Therapeutics has announced an agreement to acquire Cypress BioPharma, enhancing its renal development capabilities. This acquisition would allow Aclipse to establish parallel development programs for kidney and gastrointestinal therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does WORQ do?

Malaysia-based co-working space provider with a goal to expand its co-working space operations. It is privately held, and is based in Malaysia.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.